We assessed whether the genomic alterations of ITGA1/ITGA2 display any clinical impacts on PCa, and thus investigated potential correlation between ITGA1/ITGA2 copy number loss and their expression levels in human prostate tumors. The gene discussed is ITGA2; the disease is prostate neoplasm.